ISRG Intuitive Surgical Inc.

Intuitive Acquires Orpheus Medical to Expand Informatics Platform for Hospitals

Intuitive Acquires Orpheus Medical to Expand Informatics Platform for Hospitals

SUNNYVALE, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced it has acquired privately held Orpheus Medical to deepen and expand its integrated informatics platform.

Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in processing and archiving surgical video.

“The addition of Orpheus will provide customers —including surgeons, patient care teams and hospitals—with ready access to and a deeper understanding of their data, which we believe may help our customers improve patient outcomes and lower total treatment costs,” said Julian Nikolchev, Intuitive’s senior vice president of corporate development and strategy.

Orpheus develops and distributes its clinical video management and analytics platform, which hospitals use across surgical disciplines. The platform offers the ability to capture and share clinical video and imaging from many sources, which may help improve physician and OR care team workflow and enable analysis of their interventions.

“Combining both companies’ innovative technologies with Intuitive’s global reach and resources will enable current and future customers easier and faster access to their data,” said Gaddi Menahem, CEO of Orpheus Medical.

Orpheus will be a wholly owned subsidiary of Intuitive. Terms of the acquisition were not disclosed.

About Intuitive

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings, and develops, manufactures and markets the da Vinci® surgical system and the Ion™ endoluminal system.

About the da Vinci Surgical System

There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery. Da Vinci systems offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

For more information, please visit the company’s website at 

Forward-Looking Statement

This press release contains forward-looking statements, including statements regarding the company’s acquisition of Orpheus Medical. These forward-looking statements are necessarily estimates reflecting the best judgment of the company’s management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: the risk that Orpheus Medical cannot successfully expand its customer base or grow revenue after closing, risks associated with integrating a newly acquired business outside of the United States, diversion of management and other resources in supporting the newly acquired business, and other risk factors under the heading “Risk Factors” in the Company’s report on Form 10-K for the year ended December 31, 2018, as updated by the Company’s other filings with the Securities and Exchange Commission.  Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “could,” “should,” “would,” “targeted,” and similar words and expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.

Contact

Global Public Affairs

Intuitive Surgical



Source: Intuitive Surgical, Inc.

PN# 1069571-RevA-US-February2020 

EN
10/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Intuitive Surgical Inc.

 PRESS RELEASE

30 years of Innovation and Impact: Dan Larson's Inspiring Story

30 years of Innovation and Impact: Dan Larson's Inspiring Story SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his f...

Carol Dou Xiao Qin ... (+2)
  • Carol Dou Xiao Qin
  • Sunny Chen

China Healthcare: The rising robotic surgical system market in China.

China’s robotic surgical system segment has grown rapidly and is expected to top Rmb70b in 2030. Targeting the fast-growing market, five domestic players have launched their robotic surgical systems, competing with Intuitive Surgical, Inc, the previous monopolist in China. Rapid technological advancements, a growing preference for minimally invasive techniques and the emergence of new players are the key growth drivers of China’s robot-assisted surgical system industry. Maintain UNDERWEIGHT.

 PRESS RELEASE

Intuitive Announces CEO Transition Effective July 1, 2025

Intuitive Announces CEO Transition Effective July 1, 2025 President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive’s boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intu...

 PRESS RELEASE

Intuitive Announces FDA Clearance of da Vinci Single Port for Transana...

Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the ...

 PRESS RELEASE

Intuitive Announces First Quarter Earnings

Intuitive Announces First Quarter Earnings SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch